Genome Engineering Solutions
Sign up today and learn more about Synthego Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Synthego Stock
Synthego is a provider of genome engineering solutions. The company offers CRISPR kits, such as the CRISPR evolution, a portfolio of synthetic RNA designed for CRISPR genome editing and research. Synthego claims that its CRISPR genome engineering technology enables scientists to easily and precisely edit the DNA of any genome. Select applications of gene editing include pathway analysis, stem cells, and diagnostics. The company also offers two products: CRISPR-edited iPS cells and Engineered Cells.
The company is headquartered in Redwood City, CA, and was founded in July 2012. Notable investors include Founders Fund, 8VC, and Menlo Ventures.
Chief Executive Officer
Chief Financial Officer